Overview
Heparin-induced thrombocytopenia with thrombosis (HIT-T) is a severe complication characterized by thrombocytopenia and paradoxical thrombosis following heparin exposure. It requires prompt recognition and discontinuation of heparin therapy to prevent significant morbidity and mortality 1.Diagnosis
Key Diagnostic Criteria: Positive serotonin release assay or functional assay for heparin-dependent antibodies 1.
Recommended Tests: Platelet count drop >50% from baseline within 1-2 weeks of heparin initiation, presence of thrombosis 1.
Grading: Use the 4Ts scoring system (Thrombosis, Timing, Thrombocytopenia, Other causes) to assess pretest probability 1.Management
First-line Treatment: Direct thrombin inhibitors (e.g., argatroban) or factor Xa inhibitors (e.g., fondaparinux) 1.
Adjunctive Treatments: Anticoagulation with alternative agents to prevent further thrombosis 1.
Specific Doses: Argatroban typically initiated at 2 mcg/kg/min, adjusted based on APTT 1.Special Populations
Pediatrics: Limited evidence; case reports suggest prednisone may be effective in severe cases with associated complications like osteolysis 1.
Comorbidities: Management strategies remain similar, focusing on alternative anticoagulation and addressing underlying conditions 1.Key Recommendations
Discontinue all forms of heparin immediately upon suspicion of HIT-T 1 (Evidence: Strong).
Initiate alternative anticoagulation with direct thrombin inhibitors or factor Xa inhibitors 1 (Evidence: Strong).
Consider prednisone in pediatric cases with severe complications like osteolysis, though evidence is primarily from case reports 1 (Evidence: Weak).References
1 Sadan N, Horowitz I, Choc L, Pikielny SS, Wolach B. Giant hemangioma with thrombocytopenia and osteolysis successfully treated with prednisone. Journal of pediatric orthopedics 1989. link